• Nem Talált Eredményt

Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen

N/A
N/A
Protected

Academic year: 2022

Ossza meg "Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen"

Copied!
27
0
0

Teljes szövegt

(1)

Medical Biotechnology Master’s Programmes

at the University of Pécs and at the University of Debrecen

Identification number: TÁMOP-4.1.2-08/1/A-2009-0011

(2)

NEUROLOGICAL

DISORDERS IN THE ELERLY

PART I

Miklós Székely and Gyula Bakó

Molecular and Clinical Basics of Gerontology – Lecture 16

Medical Biotechnology Master’s Programmes

at the University of Pécs and at the University of Debrecen

Identification number: TÁMOP-4.1.2-08/1/A-2009-0011

(3)

Neurological disorders in the elderly

Age-related morphological alterations in the central nervous system

• The weight of the brain decreases

• Protein content of the brain decreases

• Neuron count declines [due to age-related decline in trophic factors such as vascular-endothelial growth factor (VEGF), brain-derived neurotrophic factor

(BDNF), insulin-like growth factor-1 (IGF-1)]

• The amount of neurotransmitters diminishes

• The number of receptor binding sites decreases

(4)

Age-related functional alterations in the central nervous system

• Impaired motor functions, declining coordination

• Difficulties in spatial orientation

• Walking speed becomes slower

• Impaired postural reflexes, loss of balance develops easier

• Sleep disorders develop frequently (superficial sleep)

• Episodic and short-term memory is especially impaired in normal aging

Large individual differences!

Neurological disorders in the elderly

(5)

The most common aging-associated neurological disorders (outline)

• Disorders of cerebral blood flow (stroke)

• Neurodegenerative diseases affecting motor (and later cognitive) (e.g. Parkinson’s disease)

• Other, more frequent neurological disorders also present in old individuals with high prevalence:

- myasthenia gravis - Headache

- dizziness (vertigo) in the elderly

• Peripheral neuropathies

(6)

The most common aging-associated neurological disorders (outline)

• Disorders of cerebral blood flow (stroke)

• Neurodegenerative diseases affecting motor and cognitive functions (Parkinson’s disease and

Alzheimer’s disease)

• Other, more frequent neurological disorders also present in old individuals with high prevalence:

- myasthenia gravis - headache

- dizziness (vertigo) in the elderly

• Peripheral neuropathies

(7)

General characteristics of the cerebral blood flow (CBF) I

• The brain (1.5 kg) is around 2% of body weight

• Cerebral blood flow represents 15% of resting cardiac output

• The brain requires 25% of resting oxygen consumption

• The brain utilizes 70% of daily glucose consumption

• CBF exhibits autoregulation: between 60-140/160 mmHg mean arterial pressure (a function of systolic and diastolic blood pressure taking into consideration the systolic and diastolic times), CBF remains stable

• Cerebral vessels show different regulation: metabolic products (CO2,  H+, adenosine, potassium) cause vasodilation,  CO2 ,  H+ elicit vasoconstriction

• No direct vasoconstrictor effect of the sympathetic tone

(8)

Autoregulation of CBF

CBF is maintained at an optimal level between 60 mmHg and 140 mmHg mean arterial pressure (MAP) due to vascular adaptation.

MAP (mmHg)

CBF (ml/min/100 g)

80 100 180

20 50 80

140 20

(9)

General characteristics of the cerebral blood flow (CBF) II

• Monroe-Kelly doctrine: the cranial compartment is

incompressible, any increase in volume of one of the cranial constituents must be compensated by a decrease in volume of another.

• Roy -Sherrington hypothesis: local neuronal activity is related to regional changes in both cerebral blood flow and

metabolism (1890).

• Because of lack of energy storage in the brain, a short cessation of blood flow (1-2 sec) leads to loss of

consciousness.

• Within 3-5 min irreversible cortical damage develops. The brainstem may tolerate 20-30 min of ischemia.

• No benefit of ischemic preconditioning (activation of adaptive mechanisms upon short-term ischemia) in the brain.

(10)

Alterations of cerebral blood flow (CBF) in the elderly

• Age-related decrease in CBF has been demonstrated in humans, primates, rodents. This decrease is regional. It affects primarily those regions of the brain (e.g. limbic, association cortex) the function of which most frequently decline in the course of aging.

• It may already start in the middle-aged.

• Density of precapillary arterioles and capillaries decrease. (In healthy aging rats, the density of arterioles on the cortical

surface was almost 40% lower in senescent animals than in young adults.)

• The structure of the vessels is also altered.

• The reactivity of the arterioles is impaired with aging.

• CBF autoregulation is largely maintained in the course of

healthy aging , but not in presence of vascular abnormalities.

(11)

Disorders of CBF in the elderly: global cerebral ischemia

Causes of global ischemia in the elderly

1 Adams-Stokes syndrome: cardiac arrest due to failure of stimulus formation and/or conduction in the heart.

2 Late phase of circulatory shocks. During shock CBF is maintained until the last phase, when autoregulation and redistribution of systemic circulation can no longer ensure minimal CBF. In case of vascular abnormalities damage is promoted.

3 Acute severe heart failure or decompensation of chronic heart failure

In the elderly somewhat diminished efficacy of autoregulation increases the risk for cerebral ischemia in global circulatory disorders.

Inappropriate antihypertensive treatment may also enhance the risk in old populations.

(12)

Disorders of cerebral blood flow in the elderly: focal cerebral infarction

Stroke = rapidly developing loss of brain function(s) due to cerebrovascular disturbances

• In industrialized countries cerebrovascular diseases present the third most frequent cause of death

following coronary heart diseases and malignant diseases.

Types of stroke

• Ischemic stroke (due to obstruction of cerebral arteries ) above 80%

• Hemorrhagic stroke (parenchymal vs.

subarachnoidal bleeding) below 20%

(13)

Prevalence of stroke by age and sex (1999-2002)

Age (years)

% of population

0.4 1.1 1.2

3.1

6.6

12.0

0.3 0.8

2.1

3.0

6.3

11.5

0,0 2,0 4,0 6,0 8,0 10,0 12,0 14,0

20 - 34 35 - 44 45 - 54 55 - 64 65 - 74 75+

Men Women

(14)

Types of focal ischemic damage

1 Transient ischemic attack (TIA)

Reversible cerebral ischemic episode with

symptoms (e.g. paralysis or weakening of limbs on one side, disturbance of speech, asymmetry of the face) lasting for 5 min to 24 h. In the background reversible obstruction of small cerebral vessels are assumed.

Within 2 years of a TIA, risk of a permanent stroke is very high!

2 Permanent ischemia (ischemic stroke)

Rapid or slowly developing irreversible progressive

ischemia with permanent complications.

(15)

Causes of ischemic stroke

1 Atherosclerosis of large vessels providing perfusion to the brain, e.g. severe obstruction of the a. carotis interna or that of a branch of the a. vertebralis), steal syndrome 2 Local thrombus formation initiated by an atherosclerotic

plaque of an intracerebral artery, e.g. that of an a.

cerebri media branch 3 Cerebral embolisation

Source: an embolus torn away from a ventricular mural thrombus (following acute myocardial infarction), from an atrial one (in atrial fibrillation, an especially prevalent

cause in the elderly) or from a large atherosclerotic

plaque of an a. carotis interna

(16)

Silent ischemic stroke

1 In 20% of neurologically “healthy” elderly people and 50% of stroke patients CT or autopsy reveal signs of previous infarctions (without prior characteristic

neurological symptoms).

2 With age, incidence of such silent infarcts increases.

3 Their presence enhance the risk of a symptomatical stroke by 2-4-times, especially white matter lesions.

4 They double the risk for dementia

5 In this case the strongest risk factors are

hypertension and sleep apnea syndrome

(17)

Other causes of cerebral ischemia

Hypertensive encephalopathy

Multiple focal microinfarctions in the brain

Mechanism: During a rapid rise in blood pressure (above the upper threshold of autoregulation) hyperperfusion with

exudation occurs in some areas and compensatory ischemia in others.

Lacunar encephalopathy (e.g. atherosclerosis, DM)

Due to obstruction of small cerebral arteries small focal infarctions of up to 15-20 mm diameter develop

Vasculitis, collagenoses, coagulation disorders Acute severe exsiccosis

Disorders of microcirculation lead to focal neurological symptoms and confusion.

(18)

Mechanisms of ischemic injury of the brain

Impaired metabolism, deficient ATP production

1 Deficiency of the NA/K ATP-ase function in ischemia leads to Na and water influx into the cells (intracellular edema).

2 Intracellular Ca level rises , resulting in neurotransmitter

(e.g. Glu) release, mitochondrial damage and other metabolic disorders.

3 Ischemia induces release of and diminishes the reuptake of excitatory neurotransmitter glutamate. Oxygen consumption and damage of the brain is further enhanced.

Free radical production

Ischemia leads to activation of xanthine oxidases, free radical

formation, cell damage, reduction in vasodilatory NO production.

(19)

Mechanisms of ischemic brain damage

Acute neurochemical changes after Ischemic Stroke

Vessel occlusion Thrombolysis /

Mechanical embolectomy Blood flow reduction

Glucose and O2 deprivation

Cytoskeletal disruption

Failure of glutamate homeostasis

 release  re-uptake

EXCITOTOXICITY Mitochondrial damage

Decreased Ca2+

buffering

 Ca2+

Oxidative stress ROS

NO / Peroxynitrite Lipid peroxidation Irreversible cell damage

Activation of cell death mechanisms ATP Depletion/Energy Failure Anaerobic glycolysis

Lactic acidosis H+

Electrochemical gradient loss:

Influx of Ca2+, Na+, Cl- H2O Efflux of K+

Depolarization

Reverse Na+/Ca2+ exchange Opening of Ca channels

(VSCC)

Ca2+ release from internal stores

Endoplasmic reticulum stress Cytotoxic edema

(20)

Therapeutic and/or preventive

measures in ischemic brain injury

Therapeutic measures

Following early diagnosis, reperfusion (neurosurgical intervention or thrombolysis) must be initiated as soon as possible (within 2-12 hours).

Preservation of the penumbra (the partially damaged brain area around the necrotic core) until reperfusion

• Lowering the temperature of the brain

• Glutamate receptor antagonists

• Barbiturates, tranquillizers

(21)

Progression of ischemic brain injury after stroke

No treatment

Neuroprotection without reperfusion

Neuroprotection with reperfusion

Improved outcome

tPA

(22)

2:15 (early) 6:00 (late)

Start of thrombolysis

• Effective and safe – in elderly as well!

• Stroke outcome 30% better

(23)

Realistic Therapeutic

Window

Stroke-induced responses in the brain parenchyma

Timeline overview of stroke induced response

Loss of Electrochemical gradients/Depolarization

Days Hours Min

Salvageable Tissue

Loss of Therapeutic Benefit

0 0 0

1 60

2 4.5 12

1 4 7

Oxidative stress Excitotoxicity Immediate Early Genes Transcription factor activation Protein misfolding/Heat Shock Proteins ER stress/Misfolded protein response Irreversible Mitochondrial damage Cytokines/chemokines Inflammation Reactive astrocyte Gliosis Angiogenesis/Regeneration

(24)

Phases of stroke-induced

alterations in the brain parenchyma

INSULT

IMMEDIATE necrotic cell death

DELAYED apoptotic cell death

Therapeutic window:

Hypothermia or others

Interventions NEED TO BE WITHIN 6 h of insult

Primary energy failure (Minutes)

Secondary phase (Hours to days) Between 6-72 h after insult

Cerebral metabolism transiently recovers Reperfusion

Na+ overload Excitotoxicity

Mitochondrial dysfunction Caspases activation

Ca ++ overload ROS, NO

Hypoxic ischemic brain injury

(25)

Causes of hemorrhagic stroke

1 Parenchymal bleeding

• Hypertension , especially combined by drug-induced iatrogenic coagulopathies, amyloid angiopathy

• Hypertension alone and in combination with drug-induced (coumarins) coagulopathy frequently occur in the elderly resulting in stroke. Their combination causes gradual slow bleeding that frequently leads to death.

2 Subarachnoidal bleeding

• rupture of cerebral aneurysm, arterio-venous malformation, head trauma, coagulopathies, amyloid angiopathy

• Head trauma is especially prevalent in the elderly due to

frequent falls. Rigidity of bridge veins linking the dura and the brain increase risk for bleeding during head trauma.

(26)

Consequences of strokes

Combination of mechanisms

An ischemic stroke may be combined with local bleeding due to

widespread collateral circulation and thrombolytic or anti-coagulant therapy.

From damaged tissues in a hemorrhagic stroke vasoconstrictor substance may be released, leading to ischemia nearby.

Brain edema with increased intracranial pressure

High intracranial pressure (Monroe-Kelly doctrine) may induce headache, nausea, vomiting, disturbed vision, Cushing reflex (high blood pressure and bradycardia), irregular breathing, confusion, convulsions, even death due to herniation

Focal symptoms

Depending on the site of injury, disturbances of vision, of speech,

dysphagia, sensory (e.g. central pain syndrome) and motor dysfunctions may develop.

Cognitive dysfunctions affect the patient and family.

(27)

Other complications of strokes in the elderly

Loss of former motor performance, immobilization

• muscle atrophy

• limb contracture

• pneumonia

• deep venous thrombosis

• pressure ulcers

• loss of former activities, isolation, depression Aggressive diagnostic tests and hospitalization

• leading to loss of self-confidence and motivation Rehabilitation must start early.

Support of family members and friends is essential.

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

• Ca 2+ -sensitive photoproteins: Aequorin (Aequoria victoria) – Emits blue light when binds Ca 2+. – First microinjected into target cell (eg. giant

development; Drosophila segmentation Nuclear hormone receptors Glucocorticoid receptor, estrogen receptor,. testosterone receptor, retinoic acid receptors Secondary

• EBF: early B-cell factor, B-cell fate determinant, turns on B- cell specific genes. • Pax5: in its absence cells are blocked at pro-B stage, self renew, broad

ZAP-70 is normally expressed in T cells and natural killer cells and has a critical role in the initiation of T-cell signaling. • ZAP-70 in B cells is used as a prognostic marker

• Cytokines: TNF, IL-1, IL-4, IL-5, IL-6, IL-13, MIP-1a, IL-3,

• After ligand binding, the tyrosine (Y) residue of the ITAM is phosphorylated by tyrosine kinases, and a signaling cascade is generated within the cell.. • An ITAM is present in

Cytokine binding dimerizes the receptor, bringing together the cytoplasmic JAKs, which activate each. other and phosphorylate

Member of a family of proteins termed neutrophins that promote proliferation and survival of neurons; neutrophin receptors are a class of related proteins first identified